Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
3(21%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
7
50%
Ph not_applicable
3
21%
Ph phase_2
2
14%

Phase Distribution

7

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
7(58.3%)
Phase 2Efficacy & side effects
2(16.7%)
N/ANon-phased studies
3(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
Recruiting3
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 17 (58.3%)
Phase 22 (16.7%)
N/A3 (25.0%)

Trials by Status

withdrawn17%
completed857%
recruiting321%
unknown214%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
14